Loading…
Impact of Infectious and Inflammatory Disease on Cytochrome P450–Mediated Drug Metabolism and Pharmacokinetics
Infection and inflammation are associated with downregulation of hepatic and extrahepatic cytochrome P450s as well as other drug‐metabolizing enzymes and transporters. We review the genesis of inflammatory reactions and discuss the relevance of the inflammation‐related regulation of cytochrome P450...
Saved in:
Published in: | Clinical pharmacology and therapeutics 2009-04, Vol.85 (4), p.434-438 |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5312-31b7b1d506f151c3de225805fad9e9b7cd954b615bc2ba67c3aeb479a1ae38823 |
---|---|
cites | cdi_FETCH-LOGICAL-c5312-31b7b1d506f151c3de225805fad9e9b7cd954b615bc2ba67c3aeb479a1ae38823 |
container_end_page | 438 |
container_issue | 4 |
container_start_page | 434 |
container_title | Clinical pharmacology and therapeutics |
container_volume | 85 |
creator | Morgan, ET |
description | Infection and inflammation are associated with downregulation of hepatic and extrahepatic cytochrome P450s as well as other drug‐metabolizing enzymes and transporters. We review the genesis of inflammatory reactions and discuss the relevance of the inflammation‐related regulation of cytochrome P450 enzymes to clinical drug–disease and drug–drug interactions. An understanding of the enzyme specificity and mechanisms of regulation will allow us to make better decisions about adjusting drug dosage regimens when a patient's inflammatory status changes.
Clinical Pharmacology & Therapeutics (2009); 85, 4, 434–438 doi:10.1038/clpt.2008.302 |
doi_str_mv | 10.1038/clpt.2008.302 |
format | article |
fullrecord | <record><control><sourceid>wiley_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3139248</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CPTCLPT2008302</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5312-31b7b1d506f151c3de225805fad9e9b7cd954b615bc2ba67c3aeb479a1ae38823</originalsourceid><addsrcrecordid>eNp9kLtu2zAUhokiReMmHbsGXDLK5UWUxCVAofRiwEE9ODNxSFExE0kUSLqFt75D37BPUqk20nbpdPDjfPwO8SP0lpIlJbx6Z7oxLRkh1ZIT9gItqOAsKwQXZ2hBCJGZZLw4R69jfJxiLqvqFTqnklHGab5A46ofwSTsW7waWmuS8_uIYWjm2EHfQ_LhgG9dtBAt9gOuD8mbXfC9xZtckJ_ff9zZxkGyDb4N-wd8ZxNo37nY_9ZsdhB6MP7JDTY5Ey_Ryxa6aN-c5gW6__hhW3_O1l8-rer368wITlnGqS41bQQpWiqo4Y1lTFREtNBIK3VpGilyXVChDdNQlIaD1XkpgYLlVcX4Bbo5ese97m1j7JACdGoMrodwUB6c-nczuJ168F8Vp1yyvJoE2VFggo8x2Pb5LSVqrl7N1au5ejVVP_FXfx_8Q5-6noDrEwDRQNcGGIyLz9xE5axks0geuW-us4f_X1X1ZluvN9s5z5_4BcN8oZs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Impact of Infectious and Inflammatory Disease on Cytochrome P450–Mediated Drug Metabolism and Pharmacokinetics</title><source>Wiley</source><creator>Morgan, ET</creator><creatorcontrib>Morgan, ET</creatorcontrib><description>Infection and inflammation are associated with downregulation of hepatic and extrahepatic cytochrome P450s as well as other drug‐metabolizing enzymes and transporters. We review the genesis of inflammatory reactions and discuss the relevance of the inflammation‐related regulation of cytochrome P450 enzymes to clinical drug–disease and drug–drug interactions. An understanding of the enzyme specificity and mechanisms of regulation will allow us to make better decisions about adjusting drug dosage regimens when a patient's inflammatory status changes.
Clinical Pharmacology & Therapeutics (2009); 85, 4, 434–438 doi:10.1038/clpt.2008.302</description><identifier>ISSN: 0009-9236</identifier><identifier>EISSN: 1532-6535</identifier><identifier>DOI: 10.1038/clpt.2008.302</identifier><identifier>PMID: 19212314</identifier><identifier>CODEN: CLPTAT</identifier><language>eng</language><publisher>Basingstoke: Nature Publishing Group</publisher><subject>Animals ; Biological and medical sciences ; Communicable Diseases - enzymology ; Communicable Diseases - pathology ; Cytochrome P-450 Enzyme System - metabolism ; Down-Regulation - physiology ; Drug Interactions - physiology ; Humans ; Inflammation - metabolism ; Inflammation Mediators - physiology ; Medical sciences ; Pharmaceutical Preparations - metabolism ; Pharmacology. Drug treatments</subject><ispartof>Clinical pharmacology and therapeutics, 2009-04, Vol.85 (4), p.434-438</ispartof><rights>2009 American Society for Clinical Pharmacology and Therapeutics</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5312-31b7b1d506f151c3de225805fad9e9b7cd954b615bc2ba67c3aeb479a1ae38823</citedby><cites>FETCH-LOGICAL-c5312-31b7b1d506f151c3de225805fad9e9b7cd954b615bc2ba67c3aeb479a1ae38823</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21242722$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19212314$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Morgan, ET</creatorcontrib><title>Impact of Infectious and Inflammatory Disease on Cytochrome P450–Mediated Drug Metabolism and Pharmacokinetics</title><title>Clinical pharmacology and therapeutics</title><addtitle>Clin Pharmacol Ther</addtitle><description>Infection and inflammation are associated with downregulation of hepatic and extrahepatic cytochrome P450s as well as other drug‐metabolizing enzymes and transporters. We review the genesis of inflammatory reactions and discuss the relevance of the inflammation‐related regulation of cytochrome P450 enzymes to clinical drug–disease and drug–drug interactions. An understanding of the enzyme specificity and mechanisms of regulation will allow us to make better decisions about adjusting drug dosage regimens when a patient's inflammatory status changes.
Clinical Pharmacology & Therapeutics (2009); 85, 4, 434–438 doi:10.1038/clpt.2008.302</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Communicable Diseases - enzymology</subject><subject>Communicable Diseases - pathology</subject><subject>Cytochrome P-450 Enzyme System - metabolism</subject><subject>Down-Regulation - physiology</subject><subject>Drug Interactions - physiology</subject><subject>Humans</subject><subject>Inflammation - metabolism</subject><subject>Inflammation Mediators - physiology</subject><subject>Medical sciences</subject><subject>Pharmaceutical Preparations - metabolism</subject><subject>Pharmacology. Drug treatments</subject><issn>0009-9236</issn><issn>1532-6535</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNp9kLtu2zAUhokiReMmHbsGXDLK5UWUxCVAofRiwEE9ODNxSFExE0kUSLqFt75D37BPUqk20nbpdPDjfPwO8SP0lpIlJbx6Z7oxLRkh1ZIT9gItqOAsKwQXZ2hBCJGZZLw4R69jfJxiLqvqFTqnklHGab5A46ofwSTsW7waWmuS8_uIYWjm2EHfQ_LhgG9dtBAt9gOuD8mbXfC9xZtckJ_ff9zZxkGyDb4N-wd8ZxNo37nY_9ZsdhB6MP7JDTY5Ey_Ryxa6aN-c5gW6__hhW3_O1l8-rer368wITlnGqS41bQQpWiqo4Y1lTFREtNBIK3VpGilyXVChDdNQlIaD1XkpgYLlVcX4Bbo5ese97m1j7JACdGoMrodwUB6c-nczuJ168F8Vp1yyvJoE2VFggo8x2Pb5LSVqrl7N1au5ejVVP_FXfx_8Q5-6noDrEwDRQNcGGIyLz9xE5axks0geuW-us4f_X1X1ZluvN9s5z5_4BcN8oZs</recordid><startdate>200904</startdate><enddate>200904</enddate><creator>Morgan, ET</creator><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>200904</creationdate><title>Impact of Infectious and Inflammatory Disease on Cytochrome P450–Mediated Drug Metabolism and Pharmacokinetics</title><author>Morgan, ET</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5312-31b7b1d506f151c3de225805fad9e9b7cd954b615bc2ba67c3aeb479a1ae38823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Communicable Diseases - enzymology</topic><topic>Communicable Diseases - pathology</topic><topic>Cytochrome P-450 Enzyme System - metabolism</topic><topic>Down-Regulation - physiology</topic><topic>Drug Interactions - physiology</topic><topic>Humans</topic><topic>Inflammation - metabolism</topic><topic>Inflammation Mediators - physiology</topic><topic>Medical sciences</topic><topic>Pharmaceutical Preparations - metabolism</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Morgan, ET</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical pharmacology and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Morgan, ET</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of Infectious and Inflammatory Disease on Cytochrome P450–Mediated Drug Metabolism and Pharmacokinetics</atitle><jtitle>Clinical pharmacology and therapeutics</jtitle><addtitle>Clin Pharmacol Ther</addtitle><date>2009-04</date><risdate>2009</risdate><volume>85</volume><issue>4</issue><spage>434</spage><epage>438</epage><pages>434-438</pages><issn>0009-9236</issn><eissn>1532-6535</eissn><coden>CLPTAT</coden><abstract>Infection and inflammation are associated with downregulation of hepatic and extrahepatic cytochrome P450s as well as other drug‐metabolizing enzymes and transporters. We review the genesis of inflammatory reactions and discuss the relevance of the inflammation‐related regulation of cytochrome P450 enzymes to clinical drug–disease and drug–drug interactions. An understanding of the enzyme specificity and mechanisms of regulation will allow us to make better decisions about adjusting drug dosage regimens when a patient's inflammatory status changes.
Clinical Pharmacology & Therapeutics (2009); 85, 4, 434–438 doi:10.1038/clpt.2008.302</abstract><cop>Basingstoke</cop><pub>Nature Publishing Group</pub><pmid>19212314</pmid><doi>10.1038/clpt.2008.302</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0009-9236 |
ispartof | Clinical pharmacology and therapeutics, 2009-04, Vol.85 (4), p.434-438 |
issn | 0009-9236 1532-6535 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3139248 |
source | Wiley |
subjects | Animals Biological and medical sciences Communicable Diseases - enzymology Communicable Diseases - pathology Cytochrome P-450 Enzyme System - metabolism Down-Regulation - physiology Drug Interactions - physiology Humans Inflammation - metabolism Inflammation Mediators - physiology Medical sciences Pharmaceutical Preparations - metabolism Pharmacology. Drug treatments |
title | Impact of Infectious and Inflammatory Disease on Cytochrome P450–Mediated Drug Metabolism and Pharmacokinetics |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T23%3A31%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20Infectious%20and%20Inflammatory%20Disease%20on%20Cytochrome%20P450%E2%80%93Mediated%20Drug%20Metabolism%20and%20Pharmacokinetics&rft.jtitle=Clinical%20pharmacology%20and%20therapeutics&rft.au=Morgan,%20ET&rft.date=2009-04&rft.volume=85&rft.issue=4&rft.spage=434&rft.epage=438&rft.pages=434-438&rft.issn=0009-9236&rft.eissn=1532-6535&rft.coden=CLPTAT&rft_id=info:doi/10.1038/clpt.2008.302&rft_dat=%3Cwiley_pubme%3ECPTCLPT2008302%3C/wiley_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5312-31b7b1d506f151c3de225805fad9e9b7cd954b615bc2ba67c3aeb479a1ae38823%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/19212314&rfr_iscdi=true |